📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease. (2015)

First Author: Ugarte A

Attributed to: MRC Brain Banks: Joint Application to Underpin Neuroscience Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/nan.12203

PubMed Identifier: 25488891

Publication URI: http://europepmc.org/abstract/MED/25488891

Type: Journal Article/Review

Volume: 41

Parent Publication: Neuropathology and applied neurobiology

Issue: 4

ISSN: 0305-1846